临床肝胆病杂志2024，Vol.40Issue(1)：42-45,4.DOI:10.12449/JCH240108
《2023年国际多学科专家共识:代谢相关脂肪性肝病和慢性肾脏病风险》摘译
An excerpt of an international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease(2023)
孙旦芹 1沈嘉琪 1郑明华2
作者信息
- 1. 江南大学附属中心医院肾内科,江苏 无锡 214000
- 2. 温州医科大学附属第一医院感染内科肝病中心,浙江 温州 325000
- 折叠
摘要
Abstract
In 2020,an international expert panel proposed to replace nonalcoholic fatty liver disease with metabolic associated fatty liver disease(MAFLD).Recent studies have shown that there is a higher risk of chronic kidney disease(CKD)in the MAFLD population and that MAFLD is an independent risk factor for CKD.However,up to now,there are still no guidelines on the prevention and treatment of MAFLD-related CKD.Based on the Delphi method,the authors led a multidisciplinary team of 50 authoritative experts from 26 countries to reach a consensus on some open-ended research issues about the association between MAFLD and CKD,which can help to clarify the important clinical association between MAFLD and the risk of CKD and improve the understanding of the epidemiology,pathogenesis,management,and treatment of MAFLD and CKD,so as to establish a framework for the early prevention and management of these two common and interrelated diseases.关键词
代谢相关性脂肪性肝病/非酒精性脂肪性肝病/肾疾病/共识Key words
Metabolic Associated Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease/Kidney Disease/Consensus引用本文复制引用
孙旦芹,沈嘉琪,郑明华..《2023年国际多学科专家共识:代谢相关脂肪性肝病和慢性肾脏病风险》摘译[J].临床肝胆病杂志,2024,40(1):42-45,4.
